The Inflation Reduction Act is a Foot in the Door for Containing Health Care Costs August 25, 2022 Perspective In this column for the JAMA Forum, KFF’s Larry Levitt explores the Medicare drug-price negotiation provisions and other significant drug-price changes in the Inflation Reduction Act and their potential to lead to further efforts to address health care costs.
Fate of Medicaid Expansion and Filling the Coverage Gap May Once Again Depend on the Outcome of State Elections August 17, 2022 Blog This post examines the potential for this year’s midterm elections to decide the fate of Medicaid expansion, with gubernatorial races in 10 of the 12 states that have not expanded, including Georgia, Kansas and Wisconsin, where the gubernatorial race is considered a toss-up. South Dakota voters also will decide a Medicaid expansion ballot initiative.
July 20 Web Event: Medication Abortion in a Post-Roe v. Wade America July 20, 2022 Event Medication abortion, also known as medical abortion or abortion with pills, has been FDA-approved as safe and effective since 2000 for the termination of pregnancies through the first 10 weeks. Its use in the United States has grown in recently years and now it accounts for just over half of…
May 23 Web Event: Executive Actions to Address Prescription Drug Affordability in the U.S. May 23, 2022 Event U.S. prescription drug spending per person is about double what it is in peer countries and about 8 in 10 U.S. adults say the cost of prescription drugs is unreasonable. With the public ranking lowering out-of-pocket costs for prescription drugs the top health care priority for Congress, lawmakers have been…
April 26 Web Event: The Future of Mental Health Coverage & Access April 26, 2022 Event Increased social isolation, stress, and unemployment as a result of the COVID-19 pandemic have contributed to a rise in mental health issues and substance use disorders (SUD) in the U.S. The impact of the pandemic has been particularly concerning for kids, as KFF’s most recent COVID Vaccine Monitor reported that…
Strategies To Lower Drug Costs Top the Public’s Health Priorities for Congress March 31, 2022 News Release Against the backdrop of public concern about inflation and rising gas prices, proposals to lower what people pay out-of-pocket for drugs tops the public’s list of health care priorities for Congress, a new KFF Health Tracking Poll finds. Most (55%) of the public say inflation is the biggest problem facing…
KFF Health Tracking Poll – March 2022: Economic Concerns and Health Policy, The ACA, and Views of Long-term Care Facilities March 31, 2022 Poll Finding This poll finds the public’s health care priorities for Congress focus on reducing out-of-pocket costs, and concerns over inflation and the economy are top of mind as voters begin to think about the November midterm elections. The poll also examines views of the ACA and nursing homes.
March 16 Web Event: Looking Ahead to the End of the Medicaid Continuous Enrollment Requirement March 16, 2022 Event Enrollment in Medicaid has grown significantly during the pandemic in large part due to the continuous enrollment requirement that prevents states from disenrolling people during the public health emergency (PHE). However, with the end of the PHE expected this year, states will resume processing redeterminations and millions of people could…
KFF COVID-19 Vaccine Monitor: February 2022 March 1, 2022 Poll Finding Two years into the COVID-19 pandemic, the public is split on their readiness to return to normal, with many worried about the consequences of lifting restrictions and of not lifting them. At this point, the pandemic is not a top issue for voters in November’s midterm elections . Most parents are not confident in the safety of the vaccine for kids under 5.
Large Shares of the Public Worry about the Consequences of Both Ending and Keeping COVID-19 Restrictions, with Partisans Largely Split on Which Direction is Most Concerning March 1, 2022 News Release As federal, state, and local authorities move to roll back COVID-19 restrictions, a new KFF COVID-19 Vaccine Monitor survey finds many people ready to get back to normal but a public also nervous about the potential consequences. Large shares of the public are worried about the implications of both keeping…